DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Blackledge G, van Oosterom A, Mouridsen H. et al.
Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study.
Eur J Cancer 1990; 26: 139-141
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.